Can Glimepiride reduce vascular inflammation in diabetic patients? How does it contribute to the prevention of cardiovascular complications?
Share
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Glimepiride can reduce vascular inflammation in diabetic patients by improving insulin sensitivity and decreasing cytokine levels, thereby mitigating cardiovascular risks.